Sanofi Cuts Jobs in U.S. Vaccines Division as Part of Restructuring

Published: Apr 19, 2024 By Tristan Manalac

Sanofi Headquarters/iStock

Pictured: Facade of Sanofi’s headquarters in France/iStock, HJBC

Sanofi has launched a sweeping restructuring initiative in its U.S. vaccines commercial operations, which will include an undisclosed number of layoffs, according to reporting by Endpoints News on Thursday.

“We are continuously adapting to the evolving U.S. vaccines market to better support our customers and patients. These changes are aimed at optimizing our commercial structure for greater efficiency and effectiveness,” a company spokesperson told Endpoints.

Though the spokesperson declined to provide details about the operations overhaul, including its timeline, scope and the number of employees that will be terminated, they said that the changes are part of Sanofi’s push to implement “a streamlined strategic sales structure.”

Sanofi has other openings within the company and the affected employees will have “opportunities to…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks